Rani Therapeutics Holdings (RANI) EPS (Basic) (2020 - 2026)
Rani Therapeutics Holdings' (RANI) quarterly EPS (Basic) came in at -$0.06 in Q1 2026, up 84.9% year-on-year from -$0.03 in Q1 2025, and up 99.96% quarter-over-quarter from -$130.44 in Q4 2025.
Rani Therapeutics Holdings (RANI) EPS (Basic) (2020 - 2026) Analysis & Trends
Rani Therapeutics Holdings' EPS (Basic) history runs 7 years deep, the most recent figure standing at -$0.06 for Q1 2026.
- On a quarterly basis, EPS (Basic) rose 84.9% year-over-year to -$0.06 in Q1 2026; TTM through Mar 2026 was -$0.23, a 86.92% increase from a year earlier, with the FY2025 full-year figure at -$1762.1, up 11.32% from the prior year.
- EPS (Basic) rose to -$0.06 in Q1 2026 per RANI's latest filing, from -$130.44 in the prior quarter.
- Across five years, EPS (Basic) topped out at -$0.06 in Q1 2026 and bottomed at -$729.39 in Q4 2022.
- The 5-year median for EPS (Basic) is -$0.66 (2022), against an average of -$115.87.
- Across the five-year window, EPS (Basic) plunged 106987.57% in 2022 and jumped 84.9% in 2026, its largest moves.
- Year by year, EPS (Basic) stood at -$729.39 in 2022, then increased by 24.45% to -$551.07 in 2023, then dropped by 0.19% to -$552.11 in 2024, then jumped by 76.37% to -$130.44 in 2025, then jumped by 99.96% to -$0.06 in 2026.
- Per Business Quant, the three latest RANI EPS (Basic) figures stand at -$0.06 (Q1 2026), -$130.44 (Q4 2025), and -$0.26 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 0.00 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 0.16 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 0.00 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 4.06 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 6.99 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 0.00 |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 7.59 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -2.29 |
| 10 | Rani Therapeutics Holdings | 160.20 Mn | 167.33 Mn | - | -0.06 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.06 |
| Dec 31, 2025 | -130.44 |
| Sep 30, 2025 | -0.26 |
| Jun 30, 2025 | -0.31 |
| Mar 31, 2025 | -0.38 |
| Dec 31, 2024 | -552.11 |
| Sep 30, 2024 | -0.63 |
| Jun 30, 2024 | -0.51 |
| Mar 31, 2024 | -0.57 |
| Dec 31, 2023 | -551.07 |
| Sep 30, 2023 | -0.72 |
| Jun 30, 2023 | -0.74 |
| Mar 31, 2023 | -0.67 |
| Dec 31, 2022 | -729.39 |
| Sep 30, 2022 | -0.66 |
| Jun 30, 2022 | -0.66 |
| Mar 31, 2022 | -0.65 |
| Dec 31, 2021 | -0.68 |
| Sep 30, 2021 | -1.48 |
| Jun 30, 2021 | -0.12 |